Galmed Pharmaceuticals (EOCN) Return on Capital Employed [ROCE] (2014 - 2024)
Galmed Pharmaceuticals (EOCN) reported Return on Capital Employed [ROCE] of 26.42% for FY2025, down 23.41 percentage points from 49.82% in FY2024.
Powered by 
Analysis
Galmed Pharmaceuticals (EOCN) Return on Capital Employed [ROCE] (2014 - 2024) Analysis & Trends
Dating back to FY2016, Galmed Pharmaceuticals' Return on Capital Employed [ROCE] record includes 10 years.
- Return on Capital Employed [ROCE] has declined for four consecutive years, with a five-year change of -26.82 percentage points (FY2020 to FY2025).
- The FY2025 figure ranks as the lowest annual Return on Capital Employed [ROCE] since FY2018.
- According to Business Quant data, Return on Capital Employed [ROCE] came in at 49.82% in FY2024 (-4.29 pp), 54.11% in FY2023 (-21.03 pp), 75.15% in FY2022 (-10.01 pp) and 85.15% in FY2021 (+31.92 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 35.41% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 17.52% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 21.60% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.65% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.91% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 17.37% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -6.15% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 11.32% |
| 10 | Galmed Pharmaceuticals | 2.06 Mn | -38.64 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 7.47% |
| Jun 30, 2023 | 0.47% |
| Mar 31, 2023 | -73.25% |
| Jun 30, 2022 | 2.82% |
| Mar 31, 2022 | -116.17% |
| Jun 30, 2020 | -43.66% |
| Mar 31, 2020 | -38.91% |
| Dec 31, 2019 | -39.80% |
| Sep 30, 2019 | -16.78% |
| Jun 30, 2019 | -20.09% |
| Mar 31, 2019 | -17.03% |
| Dec 31, 2018 | -18.27% |
| Sep 30, 2018 | -21.93% |
| Jun 30, 2018 | -35.82% |
| Mar 31, 2018 | -120.93% |
| Dec 31, 2017 | -164.32% |
| Sep 30, 2017 | 117.70% |
| Jun 30, 2017 | 118.37% |
| Mar 31, 2017 | 149.47% |
| Dec 31, 2016 | 126.19% |
API Access
Galmed Pharmaceuticals Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=EOCN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "EOCN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=EOCN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();